From culturomics to metagenomics: the mycobiome in chronic respiratory diseases

Louise-Eva Vandenborght, Raphaël Enaud, Noémie Coron, David Denning, Laurence Delhaes

Source: Eur Respir Monogr 2019; 83: 88-118
Journal Issue: The Lung Microbiome
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Louise-Eva Vandenborght, Raphaël Enaud, Noémie Coron, David Denning, Laurence Delhaes. From culturomics to metagenomics: the mycobiome in chronic respiratory diseases. Eur Respir Monogr 2019; 83: 88-118

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The microbiome in chronic respiratory diseases
Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice?
Year: 2017


The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019



The microbiome and childhood respiratory diseases
Source: International Congress 2018 – Microbiomes in respiratory disease
Year: 2018


Targeting the microbiome in respiratory diseases
Source: International Congress 2018 – Microbiomes in respiratory disease
Year: 2018


Co-occurrence analysis relates a macrolide resistome to the pulmonary microbiome in chronic respiratory disease
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012


The airway mycobiome and its relevance to respiratory disease
Source: International Congress 2019 – PG16 Assessment and analysis of the lung microbiome
Year: 2019


Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013

Metagenomic analysis of lower airway microbial diversity in patients with chronic pulmonary disease
Source: Annual Congress 2011 - Mechanisms and outcomes of infective exacerbations of COPD
Year: 2011


The global burden of chronic respiratory diseases
Source: ISSN=ISSN 1810-6838, ISBN=, page=20
Year: 2006

Prioritised research agenda for prevention and control of chronic respiratory diseases
Source: Eur Respir J 2010; 36: 995-1001
Year: 2010



Gut microbiomes in chronic obstructive pulmonary disease
Source: International Congress 2018 – Microbiomes in respiratory disease
Year: 2018


LSC - 2020 - The respiratory microbiome and metabolome in chronic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – What is new in interstitial lung diseases of known origin?
Year: 2020




Bacterial dysbiosis in pediatric lung diseases such as asthma and CF
Source: Virtual Congress 2020 – Bugs secret's: the way the microbiome changes our future
Year: 2020


LSC Abstract – Functional metagenomics of respiratoy microbiome in exacerbated COPD
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015

Characterising the respiratory microbiome
Source: Eur Respir J, 53 (2) 1801711; 10.1183/13993003.01711-2018
Year: 2019



Bacterial and viral microbiomes in COPD exacerbations of unidentified cause
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014